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I ntroduction
An increasing focus on the biomedical determinants of the health of embryos and fetuses is
resulting from new technical possibilities, clinical considerations and research purposes
(Nisker and White, 2005), but also from social factors, and for a variety of reasons. An
exploration of the determinants of health of embryos, just as an exploration of the determinants of child or adult health, must take into consideration traditional social determinants, including those related to the consequences of poverty, such as poor nutrition and
toxic environments (World Health Organization, 1948; Wilkinson and Marmot, 2003;
Raphael, 2004), but also laws, policies and institutions, which are also social determinants
of health (Wilkinson and Marmot, 2003).
The increasing focus on determining the biomedical health of embryos or fetuses may
have profound effects on the concept of health, not only as applied to these entities but as
applied to existing children and adults. Conversely, concepts of both the biomedical and
social health of children and adults may have profound effects on concepts of the biomedical and social health of embryos and the development of strategies to make such
determinations. Accepting a purely biomedical concept of health empowers certain people
and institutions with the ability to define health and manage healthcare, while simultaneously excluding others (Lippman, 1988).
We will use the term 'embryo health' in the understanding both that terms such as
'pre-embryo' (Handyside, Kontogianni, Hardy et at., 1990; Nisker and Gore-Langton, 1995;
Spallone, 1996), 'embryo' and 'fetus' represent a continuum of cell divisions and differentiations, and that attempts to construct distinctions based on time from fertilization are artificial
and often derived for vested purposes and interests (Spallone, 1996; Fox, 2000; Post, 2003).
However, we acknowledge that in some circumstances, an embryo and viable fetus should be
viewed differently. Although not a person, the human embryo is a social entity (Duden, 1993;
Franklin, 1997), and making determinations about the health of an embryo is always a socially
informed process. Discussions about determinants of the health of the embryo must include
both the in vitro and in vivo embryo, as well as the purposes for determining its health.
We explore the concept of embryo health by first examining the biomedical determinants of health under which embryos may be scrutinized and the purposes for which
such biomedical determinations are made. We then examine the traditional social determinants of child and adult health and their relation to embryo health. Next we explore the
effect of biomedical and social determinants of the health of embryos on constructing new
The 'Healthy' Embryo: Social, Biomedical, Legal and Philosophical Perspectives, eds. J. Nisker, F. Baylis, I. Karpin,
C. McLeod and R. Mykitiak. Published by Cambridge University Press. © Cambridge University Press 2010.

ways to characterize the health of children and adults, including persons living with disabilities and those not yet born with disabilities. Following this discussion is an exploration
of the differences between social determinants of embryo health that affect the biomedical
health of children, and biomedical determinants of embryo health that are directed towards
enhancing the perceived social health of children and their parents. Finally, we examine the
implications of different concepts of health on determinations of the health of embryos,
children and adults. Throughout this chapter, we locate considerations of the health of the
embryo as social practices, existing in political, economic and social contexts, and we
acknowledge that norms and values about child and adult health infuse determinations of
embryo health and vice versa.

Bi omedical determinants of the 'health' of embryos
In genetics laboratories, determinations of extra chromosomes or absent chromosomes, as
well as deletions, additions and translocations of parts of chromosomes are made through
viewing photomicrographs and other representations of chromosomes (Melotte, Debrock,
D'Hooghe et at., 2004), frequently enhanced by fluorescent in situ hybridization (FISH)
(Delhanty, Griffin, Handyside et at., 1993). Detection of markers for an increasing number
of genetic conditions (Verlinsky, Rechitsky, Sharapova et at., 2004; Marchini, Donnelly and
Cardon, 2005) are made through determinations of specific DNA sequences after their
amplification by polymerase chain reaction (PCR) (Mullis and Faloona, 1987). In 2004,
PCR determinations of the health of embryos were reported for more than 300 genetic
conditions (Verlinsky, Rechitsky, Sharapova et at., 2004).
Preimplantation genetic diagnosis (PGD) allows biomedical determinations of embryo
health to be made from a single cell from an in vitro fertilization (IVF) embryo (Handyside,
Kontogianni, Hardy et at., 1990), instead of through amniocentesis at 16 weeks gestational
age (Serr, Sachs and Danon, 1955) or chorionic villus sampling (CVS) a few weeks earlier
(Neilson and Alfirevic, 2006), obviating the need for consideration of abortion for genetic
reasons (Nisker and Gore-Langton, 1995). However, PGD requires the woman to accept the
risks of harm from IVF drugs (Abramov, Elchalal and Schenker, 1999), surgery (Alsalili,
Yuzpe, Tummon et at., 1995), and a decreased chance of becoming pregnant (Nisker and
Gore-Langton, 1995; Mastenbroek, Twisk, Echten-Arends et at., 2007). IVF clinics are
increasingly employing 'routine screening' of IVF embryos or polar bodies for chromosomal anomalies to avoid both miscarriages (Verlinsky, Rechitsky, Sharapova et at., 2004)
and children 'affected' by irregular chromosome patterns.
In IVF laboratories prior to the advent of embryo cryopreservation (Trounson and Mohr,
1983), microscopic determinations of embryo health, including evidence of cell division, lack
of fragmentation and blastomere symmetry and clarity, were undertaken in an attempt to
determine the three (or more) 'best' or 'most suitable' embryos to transfer to the woman's
uterus, with the remaining embryos discarded to avoid high-order multiple pregnancy
(Lornage, Chorier, Boulieu et at., 1995; Van Voorhis, Grinstead, Sparks et at., 1999;
Soderstrom-Anttila, Foudila, Ripatti et at., 2001; Newton, McDermid, Tekpetey et at., 2003;
Nisker, White, Tekpetey et at., 2006). For the past 15 years, embryos not transferred in the
IVF treatment cycle have been cryopreserved for later transfer to the woman so that she may
avoid the harms of additional IVF cycles (Alsalill, Yuzpe, Tummon et at., 1995; Abramov,
Elchalal, and Schenker, 1999).
The purpose of making a biomedical determination of the health of an embryo may
alter perceptions of the health or suitability of embryos. For example, if the purpose of a
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determination is to prevent having a child who would develop an X-linked recessive
condition, the health of an embryo with a Y chromosome is viewed differently than if the
purpose of the determination is to select the gender of a child for social reasons. Similarly,
when identifying a DNA sequence associated with deafness (Levy, 2002) or dwarfism (Saito,
Sekizawa, Morimoto et al., 2000; Nunes, 2006), whether the purpose of the deterixination is
to prevent giving birth to a child who is deaf or of short stature or to purposefully have a
child with such a characteristic determines how the DNA sequence is viewed. Another
example of how the same biomedical determinant of embryo health may be viewed differently because of its purpose is the testing an embryo for its suitability (after birth) to be a
stem cell 'donor' for an ill child (Pennings, Schots and Liebaers, 2002; Verlinsky, Rechitsky,
Sharapova et al., 2004). For this purpose, embryos that would be seen as healthy and
suitable for implantation based on biomedical determinations made for any other purpose,
but are determined not to be histocompatibly suitable for stem cell 'donation' to the in
child, are discarded (please refer to Sheldon and Wilkinson, Chapter 17).
Research purposes may also alter perceptions of the biomedical health of embryos. For
example, some stem cell researchers believe that 'fresh' embryos are preferable to cryopreserved embryos (donated after the woman no longer requires them for her reproductive
purposes) for their purpose (Nisker and White, 2005). This preference has encouraged a
recent revival of interest in microscopic determinants of the health of IVF embryos, and
those embryos determined as likely to be unhealthy or unsuitable are 'donated' 'fresh' to
stem cell research (Nisker and 'White, 2005; Nisker, White, Tekpetey et al., 2006; McLeod
and Baylis, 2007). No evidence exists that an embryo's potential to become a child can be
completely ruled out until it stops dividing and degenerates (Newton, McDermid, Tekpetey
et al., 2003). In Australia, where until recently, all additional IVF embryos were viewed as
having the capacity to be healthy, no 'fresh' embryos were donated to research (Nisker,
White, Tekpetey et al., 2006). However, in response to a desire of Australian stem cell
researchers to use 'fresh' embryos for their research purposes, a recent National Health and
Medical Research Council guideline (National Health and Medical Research Council
[NHMRC], 2007) describes morphologic criteria by which embryos may be declared less
healthy or less suitable and thus can be 'donated' 'fresh' to stem cell research.

Social determinants of the 'health' of embryos
The concept of social determinants of health emerges from the World Health Organization
(WHO) definition of health (World Health Organization, 1948) and recognizes that economic and social conditions influence the health of individuals and communities (Raphael,
2004). These social determinants include factors such as ethnicity, community structure,
economics and law (Frazee, Gilmour and Mykitiuk, 2002; Siegler and Epstein, 2003), as well
as education, employment, working conditions, nutrition, healthcare services, transportation, housing, income and social inclusion (Hofrichter, 2003; Raphael, 2004). A social
determinants approach reveals the ways in which health is dynamically produced within
specific social environments and political contexts and by culturally informed perceptions
of an individual's bodily experiences and functions (Krieger, 2005).
Many of the social determinants of health considered important for the biomedical health
of children and adults may also be important determinants of the biomedical health of
embryos. For example, poverty and its related social determinants of health, such as poor
nutrition, toxic environment and infectious diseases can, when related to the health of women,
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both prior to and during pregnancy, become social determinants of health of the embryo.
Social determinants of health of embryos, such as malnutrition (Stanner, Bulmer, Andres
et al., 1997; Eriksson, Forsen, Tuomilehto et al., 1999; Roseboom, Van Der Meulen, Osmond
et al., 2000; Montgomery and Ekbom, 2002; Plagemann, Rodekamp and Harder, 2004)
including folic acid deficiency (Koren, 1993), and toxic environment (Peakall, Hallett, Bend
et al., 1982; Jarrell, Gocmen, Foster et al., 1998) can result in biomedical impairments for the
children they become. Poverty during pregnancy is associated with an increased incidence of
smoking (Quinton, Cook and Peek, 2008), alcohol consumption (Koren, 1991), and drug
addiction (King, 1997), all of which affect the embryo and could result respectively in fetal
hypoxemia (Socol, Manning, Murata et al., 1982; Ng and Zelikoff, 2007), fetal alcohol syndrome (Centers for Disease Control and Prevention [CDC], 2004; Chudley, Conry, Cook
et al., 2005), and crack cocaine syndrome (Singer, Minnes, Short et al., 2004). Maternal poverty
is also related to an increase in viral infections and other pathogens, which, when present
during pregnancy, may affect the health of the embryo and eventually the health of the child
that embryo may become (Goldenberg, Hauth and Andrews, 2000; Feigin, 2005).
These social determinants of embryo health can also have long-range effects on the
biomedical health of the adults the embryos become (generally referred to as the 'Barker
Hypothesis') (Barker, 1992). Research on a cohort of adults whose mothers were pregnant
with them during the Dutch famine from 1944 to 1945 indicated that nutritional deprivation of pregnant women resulted in coronary artery disease in their offspring 50 years later
(Roseboom, Van Der Meulen, Osmond et al., 2000). Further, studies have shown an
association, particularly in animals but also in humans, of nutritional deprivation and other
factors, not only in coronary artery disease (Eriksson, Forsen, Tuomilehto et al., 1999;
Roseboom, Van Der Meulen, Osmond et al., 2000), but in type II diabetes (Stanner,
Bulmer, Andres et al., 1997; Ravelli, Van Der Meulen, Michels et al., 1998; Montgomery
and Ekbom, 2002; Plagemann, Rodekamp and Harder, 2004).
Another social determinant of the biomedical health of the embryo is that women
are delaying becoming pregnant (Nybo Andersen, Wohlfahrt, Christens et al., 2000;
Hammarberg, Clarke, Tough et al., 2002), a factor that is conditioned by social and cultural
contexts. Delaying pregnancy is increasingly common (most often in developed nations) for
a variety of social reasons (Gosden and Rutherford, 1995; Hammarberg and Clarke, 2005;
Nisker and Bergum, 2007), including pursuit of education, career and financial independence and being in a committed relationship. Because older women have an increased
susceptibility to giving birth to children with chromosomal aneuploidy (Heffner, 2004;
Society of Obstetricians and Gynaecologists of Canada [SOGC], 2007; Summers, Langlois,
Wyatt et al., 2007), they are more likely to undergo amniocentesis (American College of
Obstetricians and Gynecologists [ACOG], 2001), chorionic villous sampling (Neilson and
Alfirevic, 2006), or PGD (Berkowitz, Roberts and Minkoff, 2006), thus exposing their
embryos and fetuses to biomedical determinations of genetic 'health.' Women who delay
childbearing are also susceptible to infertility due to oocyte depletion (Pastor, Vanderhoof,
Lim et al., 2005), recurrent miscarriages (Benzies, 2008), endometriosis (Mishell, 2001), and
fallopian tube damage (Mishell, 2001), and are thus more likely to undergo IVF, which
exposes their embryos to a variety of biomedical determinants.
The association of advanced age and infertility has resulted in an increase in the use of
fertility drugs, which can lead to an increase in multiple pregnancies and in children born
prematurely (Drack, 1998; Barrett and Bocking, 2000; Elster, 2000; Adamson and Baker,
2004; Inder, Warfield, Wang et al., 2005). These children have a preponderance of
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long-term health problems (Drack, 1998; Barrett and Bocking, 2000; Elster, 2000; Adamson
and Baker, 2004; Inder, Warfield, Wang et al., 2005). If the social and economic factors
leading to infertility were addressed so that women could be having children earlier and
could be subject to fewer internal and external environmental 'causes' of infertility (Hull,
1991), the 'need' for IVF
Glazener, Kelly et al., 1985; Thonneau, Marchand, Tallec et al.,
would be reduced along with the corresponding problems relating to embryb 'health'. One
solution is to direct resources to infertility prevention strategies, such as reducing the
incidence of sexually transmitted diseases, investing in changing the social conditions and
correcting environmental conditions that contribute to infertility.
Although the fact of gestation focuses our attention on the relationship between
maternal health and that of the embryo, paternal exposure to environmental and occupational
toxins may, through genetic mutations in sperm, also affect the health of embryos, including
those that become children (Singh, Muller and Berger, 2003; Thacker, 2004; Rubes, Selevan,
Evenson et al., 2005; Zini and Libman, 2006). A relationship has been observed between
embryo health and paternal smoking, drug use and alcohol use (Rubes, Selevan, Evenson
et al., 2005; Zini and Libman, 2006). Further, men who are addicted to drugs or alcohol help
to create a social environment that can harm maternal and embryo health. For example,
male partners may encourage or pressure pregnant women to continue to use alcohol or
drugs (Chavkin, Paone, Friedmann et al., 1993). In addition, drug or alcohol addiction on
the part of women, including those who are pregnant, is often a coping mechanism for
dealing with the trauma of sexual and other forms of abuse (Silverman, Decker, Reed et al.,
2006). Pregnant women are more likely than non-pregnant women to be victims of
domestic abuse (SOGC, 2005).
Economic factors are also social determinants of health (World Health Organization,
2005). Particular to embryo health, economic factors include allocation of resources to
improve the social determinants of maternal and embryo health. Economic factors also
facilitate access to the procedures that place embryos under DNA or microscopic lenses, as
well as influencing the purpose for which they are placed under the lens. In some countries,
economic factors allow some prospective parents to make determinations of embryo health,
thus empowering some individuals, but not others, to make personal choices about genetic
risk. In a social context that does not adequately support and accommodate people with
impairments and their families, decisions about using PGD, amniocentesis or CVS to assess
embryo health may be influenced by the perceived economic and social costs of having a
genetically 'unhealthy' child.
The economic factor of low income predisposes some women in Canada and the United
States to use fertility drugs without the safety of IVF and single embryo transfer, resulting
in an even greater risk of multiple pregnancy and its consequences (Min, Claman and
Hughes, 2006; Mykitiuk and Nisker, 2008). Equal access to IVF as exists in many European
countries and Australia would decrease the impact of the social determinant of low income
and its biomedical effects. However, IVF and fertility drugs may have long-term health
effects on the child and adult that embryo may become, particularly in relation to
et al.,
Angelman syndrome (Cox, Burger, Lip et al., 2002; Orstavik, Eiklid, van der Hagen
2003) and Beckwith-Wiedemann syndrome (DeBaun, Niemitz and Feinberg, 2003; Maher,
Brueton, Bowdin et al., 2003).
Further, any economic arguments must consider the financial costs of caring for premature neonates in the neonatal intensive care unit, as well as the care required to assist the
children that survive with 'disabilities' (Barrett and Bocking, 2000; Gilbert, Nesbitt and
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Danielsen, 2003; Phibbs and Schmitt, 2006; Nisker, 2008). The economic factors that
influeiice who can access IVF, PGD, amniocentesis and CVS, and for what 'conditions'
inform and are informed by prevailing conceptions about what health is, which in turn are
products of social ideologies, institutions and decisions about the allocation of resources.
Regulation is also an important social determinant of health. The law establishes the role
of the state in relation to improving health (Siegler and Epstein, 2003; Krieger, 2005), as
well as creating and shaping the conditions within which health can be achieved (Frazee,
Gilmour and Mykitiuk, 2002). Further, regulation plays an important role in shaping what
we view as health, including the characterization of the health of embryos. Although a legal
examination of what constitutes a healthy embryo is beyond the scope of this exploration, it
should be noted that no jurisdiction has a comprehensive regulatory framework (such as a
Healthy Embryo Act) that defines what a healthy embryo is and the conditions within which
to achieve it. Rather, in Canada, the United Kingdom, Australia, New Zealand, France and
Germany, an array of statutes, regulations, policy and case law form a corpus of jurisprudence about the embryo that examines a range of issues, including the legal status of the
embryo; the legal consequences of harm to a fetus or embryo; judicial intervention into
pregnancy; and the regulation of embryo research, creation, destruction, disposition and
donation.
Although law exists pertaining to embryos and fetuses, we found scant reference to the
health (and cognates) of an embryo or its ill health (and cognates). Moreover, in no
legislative documents are any of these terms when used in relation to an embryo, ever
defined. Thus, the legal conception or definition of health in relation to the embryo is most
often a matter of judicial interpretation, often relating to the ultimate utility or purpose of
the embryo. Indeed, even the legal definition of the terms 'embryo' and 'fetus' shift among
jurisdictions and contexts (Fox, 2000).
A social determinants approach demonstrates that responsibility for embryo health
rests not only on individual women but is shared with men, public institutions and social
structures. For example, poor nutrition, toxic environments (including workplaces), drug
and alcohol use, and poverty and violence, when mediated through the bodies of pregnant
women, are all profoundly social determinants of embryo health. Inadequate social
structures and social exclusion also have consequences, such as poverty, lack of education,
poor employment, and poor healthcare, all of which can contribute to maternal or
paternal behaviours and, through them, to poor embryo health (please refer to Karpin,
Chapter 10).
A social determinants approach to embryo health requires us to attend to the social
environments in which women, men and embryos exist, rather than locating health and
illness exclusively within the individual body be it an embryonic body or that of a
person. This role of social environments is important to acknowledge, especially when
biomedical assessments of embryo health are increasingly focused on embryos that have
been created outside of women's bodies but are dependent on women's embodiment for
gestation and birth. Optimizing the health of all embryos, not just those created by IVF,
requires that we attend to the maternal and paternal 'environment' as a determinant of
health of the embryo. Concern about the maternal environment itself requires us to care
for and about the pregnant woman (i.e. ensuring adequate nutrition and prevention of
exposures to toxins in the environment and workplace), because through her, embryo
health is affected. In a social determinants approach, the health effects on the embryo are
'socialized' and not just 'individualized'.
-
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Interwoven implications of determinants of the health
of embryos, children and adults
Just as biomedical and social determinants of the health of an embryo are informed by ideas
and evaluations of the characteristics of the child that embryo may become, as well as
concepts of 'health', 'disease', 'illness', 'well-being' and 'disability' in children and adults,
determinations of embryo health have implications for our perceptions of the social and
biomedical health of children and adults. Biomedical and social determinants of embryo
health share the assumption that the condition of health can not only be identified in
embryos but that such a determination is important when considering the health of children and adults. Although the means and conditions through which health is determined
and produced differ with biomedical and social approaches, health is construed by each as a
goal worthy of pursuit and funding. Implicit in both biomedical and social determinants of
health is the idea of an optimal, or at least preferred, normative concept of health and the
possibility of making positive and negative evaluations of health. Therefore, we must attend
to the criteria, both factual and normative, through which we assess the biomedical and
social determinants of the health of embryos, and consider how such determinations are
and ought to be made and the impact of such determinations of health on current and
future children and adults.
Common to many understandings of health are the notions of absence of illness or
disease and the normative functioning of biological systems (Woibring, 2005). With these
understandings, the aim of medicine is to prevent, diagnose and treat disease and illness.
When an anomalous characteristic in morphological, functional or genetic make-up is
detected, medicine aims to restore to 'species-typical functioning' the person who has lost
her perceived biological health because of unfavourable biomedical or social determinants
(Buchanan, Brock, Daniels et al., 2000), which is achieved through treatment, rehabilitation
or management of the impairment.
In the case of an embryo, to prevent the person born of a specific embryo from
exhibiting disease, disability, impairment or sub-normative functioning, either discarding
the embryo or performing an abortion is required (Buchanan, Brock, Daniels et al., 2000),
except in rar e situations where strategies for correction can be employed during pregnancy
or following birth, such as fetal surgery for open neural tube defect (Botto, Moore, Khoury
et al., 1999) or cardiac anomaly (Harrison, 1996). Thus, rather than biomedical determinations of embryo health being strategies for preventing ill health (Steinbock, 2000;
Shakespeare, 2006), they are generally techniques for selection (Asch, 2000; Parens and
Asch, 2000; Asch, 2003; Asch and Wasserman, 2005). Alternatively, prevention of the
impairment in the person whom that embryo may become can be achieved by improving
social determinants of maternal health, such as better maternal diet, increasing the intake of
folic acid, or reducing alcohol consumption (please refer to Karpin, Chapter 10).
The exponential increase in research funding in genomics will probably result in the
identification of a genetic contribution to many human differences. How these differences are
interpreted, placed into context, and acted upon could have social implications for current and
future persons. In addition, genomics research will create new biomedical and social determinants of embryo health, which could in turn have implications on the perceived health of
children and adults. For example, the differences in the DNA sequences in the genotypes of
'healthy-appearing persons are called 'polymorphisms'. However, when a polymorphism is
correlated with a particular 'phenotype' (observable expression of genotype), it becomes a
122
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'mutation' (Gerald Kidder, personal communication, 2005). Once a DNA sequence is termed a
'mutation', embryos with this mutation may be viewed as unhealthy and then become the
targets of the new clinical purpose of preventing individuals having these mutations through
the use of PGD. Further, because the word 'mutation' could have a pejorative connotation, once
the correlation between a genetic polymorphism and a particular phenotype is determined,
children and adults with previously considered anomalous characteristics become children and
adults with mutations, and could be viewed differently. However, the detection of a marker for
a mutation does not alter the health of the potential child. Further, because the phenotypic
expression of a gene may vary considerably (Morley, Molony, Weber et al., 2004), and social
determinants, such as education, family and government support, could greatly moderate the
impact of the presence of an anomalous characteristic, whether or not a correlation with a
mutation is known.
Social responses to the characterization of a trait as a mutation rather than a variance may
have a profound impact on the social health of a child carrying a mutation. For example, the
social perception and treatment of a child with 'attention deficit syndrome' may be dramatically altered if a mutation for this condition is discovered, thereby turning a learning
difference into a genetic condition that could be 'prevented'. A child with a genetic mutation
may be viewed differently from a child who may require specific social and educational
services and accommodations. Children resulting from embryos with a mutation that could
have been genetically tested and discarded may be looked upon as 'drains' on educational and
social welfare systems, and their parents may be viewed as irresponsible for not preventing
such drains (Rothman, 1986; Nisker and Bergum, 1999; Mykitiuk, 2002; Nisker and Bergum,
2007). Further, all children with learning-specific needs may eventually be looked upon as
having a disease for which a gene mutation has not yet been found, rather than as individuals
exhibiting characteristics within the wide and diverse range of human attributes.
As more biomedical determinants of embryo health become available to scrutinize indicators of the 'qualities' and characteristics of the prospective child, particularly those qualities
that are socially valued and desired, social values and preferences about personal characteristics
could become conflated with the health of the embryo. Giving social preferences a medical
status, through their biomedical determinations in healthcare facilities and frequently through
public funding, not only masks the fact that they are merely social preferences but simultaneously detracts attention and resources from the actual social determinants of health of embryos
and children. For example, prospective parents who believe their child's social health and wellbeing are determined by factors related to enhanced cognitive capacity have, for more than 30
years, been creating embryos through the purchase of sperm from genius sperm banks (Flint,
2006). Similarly, prospective parents who believe their child's social health or well-being is
determined by physical appearance can bid for the oocytes of 'Ron's Angels', 'models' whose
photographs and other descriptors appear on the Internet (Nisker, 2001, 2002; Harris, 2003).
Such attempts to enhance a child's social health and well-being may also inform uses of PGD to
detect or select for qualities in the embryo, further calling into question the bases upon which
determinations of embryonic and child health are made.
Determinations- of embryo health are informed not only by concerns about the biomedical and social health of the child who may be born from that embryo, but considerations of the social health and well-being of third parties. For example, prospective parents
may perceive their social health to be determined, or at least influenced, by having a
'healthy' child, or a child with specific characteristics, thereby justifying their use of technology to determine the biomedical health of the embryo. This perception could be shared
123
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by potential parents who feel that they do not have the physical, emotional, social or
financial resources to care for a child with a genetic 'condition', and potential parents who
knowingly or unknowingly want to enhance how others view them by enhancing physical
and cognitive characteristics of their children.
The use of PGD to select for genetic traits perceived by many to be associated with ill
health or impairment, such as deafness (Levy, 2002; Savulescu, 2002), raises additional issues
regarding the relationship between embryo health and that of children and adults. Just as
lesbian members of the deaf community have used donor sperm (Levy, 2002; Savulescu, 2002)
to increase their chances of having a child who is deaf, a couple seeking to use PGD to have a
child who is deaf may be acting in an analogous manner to prospective parents who are legally
allowed to access biomedical determinants to promote in their children the qualities they
associate with social health. However, in New Zealand, the Guidelines on Preimplantation
Genetic Diagnosis 2005 prohibit the use of PGD for the selection of 'embryos with a genetic
impairment seen in a parent'. In Australia, Victoria's Infertility Authority has also specifically
prohibited 'the use of PGD to select in favour of genetic disease or abnormality on the basis
that it would be inconsistent with the first guiding principle of their Act: 'the welfare and
interests of any person born or to be born as a result of a treatment procedure are paramount'. In both countries, the legislation justifies the prohibitions according to the need to
protect and ensure the best interests, well-being and health of children born as a result of
PGD (neither piece of legislation, however, defines health) (Van Wagner, Mykitiuk and
Nisker, 2008). However, it could be argued that such legislation regarding embryos may cause
children and adults who are deaf to be seen as having a disease worth preventing (as well as
not selecting for) (please refer to Sheldon and Wilkinson, Chapter 17).
The use of PGD to select embryos for the purpose of becoming a stem cell 'donor' (after
birth) for an ill sibling serves as an example of third-party interest, as well as a model to
further explore the concept of the health of an embryo and its relationship to the health of a
child. In the situation of selecting an embryo to be a child who can be a stem cell donor (a
'saviour sibling'), embryos that are healthy according to biomedical determinants but lack
the histocompatibiity characteristics consistent with being a stem cell donor are discarded,
as are embryos with markers for the ill child's genetic condition (Verlinsky, Rechitsky,
Sharapova et al., 2004).
In the United Kingdom, the use of PGD was permitted to select for an embryo to be a
stem cell 'donor' (histocompatibiity matched) for an ill sibling with an inherited condition
(Human Fertilisation and Embryology Authority, 2001; Dyer, 2002), while in another case,
the use of PGD for the purpose of selecting embryos for stem cell 'donation' was refused
because the ill child did not have a genetic mutation for an inherited disease (Hall, 2002;
Gavaghan, 2004; Sheldon and Wilkinson, 2004). In the former case, PGD was permitted to
avoid having a child with a serious inherited disease of which the family was at risk, and
thus performing PGD would constitute a health benefit to the child who developed from the
embryo that had been screened, making it possible to prevent the birth of a child with a
genetic condition. However, in the latter case 'the legal condition of allowing PGD to avoid
serious disease was not applicable' (Bellamy, 2005) because the embryo was not at risk of
having a gene for an inherited condition, and 'selection for an HLA [human leukocyte
antigen] match alone would have no diagnostic and preventive function and would,
therefore, set a new precedent of PGD being used solely for the purpose of creating
offspring with specific desired traits' (Franklin and Roberts, 2006, p. 65) (please refer to
Sheldon and Wilkinson, Chapter 17, for the current situation in the United Kingdom).
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A similar logic animates the New Zealand Guidelines on Preimplantation Genetic
Diagnosis (National Ethics Committee on Assisted Human Reproduction, 2005) that
restricts PGD for HLA tissue typing to situations where there are 'therapeutic indications
for the embryo to justify embryo biopsy (Human Genome Research Project, 2006; Van
Wagner, Mykitiuk and Nisker, 2008). This policy permits tissue typing where both the live
child who would be the recipient of the transplant and the embryo are at risk of being
affected by a 'familial single gene disorder or a familial sex-linked disorder' (National Ethics
Committee on Assisted Human Reproduction, 2005, p. 6).
Restricting PGD to cases in which the 'embryo may benefit' (Gavaghan, 2004; Sheldon
and Wilkinson, 2004) or have a 'therapeutic indication' (Human Genome Research Project,
2006) is problematic as an embryo cannot 'benefit' from the removal of a blastomere or
blastocyst tissue (and its genetic testing), nor can a 'therapeutic intervention' occur for an
embryo, although fetal surgery is sometimes a possibility for anomalies such as those related
to the cardiovascular and neuroskeletal systems (Harrison, 1996; Botto, Moore, Khoury et al.,
1999). Rather, the 'benefit' or 'therapeutic indication' implied in the United Kingdom and
New Zealand examples is the destruction of the embryo: the antithesis of both a 'benefit' and
a 'therapeutic indication' for that embryo. PGD does not provide a benefit to the embryo that
is found not to have a genetic marker or the future child resulting from that embryo because
the health of the future child is in no way improved by PGD. Rather, these embryos that are
found not to carry a genetic marker have a slightly decreased chance of becoming a child
because of the PGD process (Mastenbroek, Twisk, Echten-Arends et al., 2007). The 'benefit'
of PGD in these circumstances accrues not to the tested embryo but to third parties: the ill
sibling who has a 'therapeutic indication' and her parents. Although the Human Fertilisation
and Embryology Authority (HFEA) has recently overturned its decision regarding not permitting PGD unless the ill child has an inherited condition (Bellamy, 2005), the New Zealand
guidelines remain in effect (please refer to Sheldon and Wilkinson, Chapter 17).
Determining the biomedical health of an embryo can have implications for the biomedical
health of adults through testing embryos for genetic markers for adult-onset conditions such
Huntington's disease (Hayden, Bloch and Fahy, 1988), BRCA-gene breast cancer (Narod,
Feunteun, Lynch et al., 1991; Narod, Lynch, Conway et al., 1993) and, most recently, Alzheimer's
disease (Verlinsky, Rechitsky, Verlinsky et al., 2002). Although an embryo carrying a gene
marker for one of these conditions would result in a person that would likely live 40 years before
the genetic condition expresses itself, because of the capacity to determine these gene markers,
embryos that would have previously been considered healthy may now be considered unhealthy.
In addition, although an embryo that is determined to have a genetic marker for Huntington's
disease is almost certain to result in a person who will eventually develop the disease (Myers,
2004), a person born from an embryo with a marker for a BRCA gene mutation has a much
lower chance of developing breast cancer (except for Ashkenazi Jewish women who have up to
an 80% chance) (Narod, Madlensky, Bradley et al., 1994), whereas a person born from an
embryo that was determined to have a gene marker for Alzheimer's disease is even less certain to
develop the disease.

The implications of different concepts of health on
determinations of the health of embryos, children and adults
Interpretations of the concept of health have implications for biomedical and social
determinations of the health of embryos, children and adults. Contrary to the common
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biomedical concept of health, variation from 'species-typical functioning' (Buchanan,
Brock, Daniels et al., 2000) is not necessarily an indication of ill health because health is
determined socially as much as it is biomedically (Davis, 1995; Taylor and Mykitiuk, 2001;
Amundson, 2005; McMahon, 2005; Thomas, 2007). Biomedical differences or deviations
from statistical 'norms' are often only indicators of poor health when declared so within a
social context (Davis, 1995, 2002; Taylor and Mykitiuk, 2001).
Just as interpretations of the concept of health have implications for biomedical and social
determinations of the health of embryos, children and adults, interpretations of the concept
of health have implications for the meaning of 'disabiliy (Frazee, Gilmour and Mykitiuk,
2002; Woibring, 2005; Thomas, 2007). Commonly 'disability refers to "limited activity" not
being able "to do things", and a "disabled person" is someone who has a medically certifiable
"condition" that prevents him or her carrying out the full range of age-related activities
considered normal' (Thomas, 2007, p. 12). This perspective 'assumes that an injury to the
is the cause
body through illness, accident or "developmental abnormalities" in gestation
of disability' (Thomas, 2007, p. 12). Disabled people as a group are often regarded as patients
who are unhealthy, where health is associated with a relationship to disease and illness and
rarely with social health or well-being. Most often, biomedical determinants are examined for
their contributions to the biological health of disabled people, whereas social determinants are
rarely examined for their contributions to the biological and social well-being of disabled
people (Wolbring, 2006). Treating disability is most often seen as a biomedical issue leading
to its medicalization, in which the appropriate response becomes 'the development of health
practices designed to reduce or eliminate the creation of people with such impairments'
(Wasserman, Bickenbach and Wachbroit, 2005, p. 12).
However, what is disabling is the inflexibility and limitations of the social and physical
environments and their failure to accommodate perceived individual variety and difference,
coupled with discriminatory and oppressive attitudes towards and treatment of people with
impairments (Taylor and Mykitiuk, 2001; Davis, 2002; Shakespeare, 2005; Wasserman,
Bickenbach and Wachbroit, 2005; Shakespeare, 2006; Thomas, 2007). Having an impairment (or a biomedical condition) in a disabling environment does not mean that one is
unhealthy, though it may be perceived that way. However, when biomedical differences in
health arise, such outcomes are more often attributable to biological (and increasingly
genetic) differences than to systemic disablism. But, even in cases where an individual does
have a genetic difference or a biomedical anomaly, the material and social environment in
which that individual lives may be more important in determining that person's health and
well-being than the genetic difference or anomaly. This situation is due to the fact that
people with impairments have less access both to health practitioners and to social determinants of health, such as education, employment, transportation and social support
(Townsend, 1979). Rectifying social and physical challenges requires environmental and
social justice responses and not individualized biomedical interventions.
The significance of environments, policies, values and services to determinations of
disability and health is evidenced in the International Classification of Functioning,
Disability and Health (ICF), the WHO's 2001 framework for describing and measuring
disability and health (World Health Organization, 2001). Organized around the broad
components of body functions (both physiological and psychological) and structure
(anatomical parts), activities (execution of actions) and participation (involvement in a life
situation), and environmental factors (World Health Organization, 2001), functioning and
disability are viewed as the outcome of the complex interaction among the biological
-

-

-
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structures and function of the individual's body and mind (often understood as impairments) and the contextual factors of the environment in which the person lives (e.g. legal
and social structures, social attitudes, architectural structures) as well as personal factors
(e.g. gender, age, education) (World Health Organization, 2001). According to the ICF
scheme, body functions and structure are divided into a number of domains, while activities
and participation are described in the domains of learning and applying knowledge; general
tasks and demands; communication; mobility; self-care; domestic life; interpersonal interaction and relationship; major life areas; and community, social and civic life. The term
'functioning' refers to all body functions, activities and participation, whereas 'disability' is an
umbrella term for impairments, activity limitations and participation restrictions. Environmental and contextual factors interact with all of these components (World Health Organization, 2001) and include products and technology; the natural and human-made changes to
the environment; support and relationships; attitudes and services; and systems and policies
(World Health Organization, 2001).
The ICF classification treats all of these dimensions as interactive and dynamic and is
neutral as to aetiology, placing the emphasis on function rather than condition or disease.
What matters are the activity limitations and/or participation restrictions (if any) experienced by the person with the disease, condition or impairment, and the means by which
such restrictions may be ameliorated. Activity limitations and participation restrictions can,
in most cases, be remedied by assistive devices, anti-discrimination laws, and education,
and, in some cases, by surgery and other forms of medical intervention.
Understanding health, disability, and functioning along the lines of the ICF renders
problematic the use of morphological characteristics and genetic markers to assess embryo
health, especially in contexts where they are intended to determine the health of the person
that embryo may become. Indeed, biomedical determinants of embryo health reinforce a
medicalized and diminished model of health and disability that runs counter to the
understanding of health and disability that informs much law and social policy (Eldridge v.
British Columbia, 1997; Granovsky v. Canada, 2000). This uncritical reliance on a single
characteristic in the embryo 'dominates the judgment of its life prospects' and 'reproduces the
stigmatization of people with disabilities at the level of reproductive choice' (Wasserman,
Bickenbach and Wachbroit, 2005, p. 14).
Western Australia's Reproductive Technology Council (RTC), responsible for assessing
applications for PGD, invokes the ICF criteria for the health of children and adults in its criteria
for evaluating the 'risk and seriousness of the condition to be tested for' (Reproductive
Technology Council, 2004), using some language that is identical to the ICF, including the
family's 'experience with, and attitude to' the condition; the 'level of impairment to body
functions and structures that is usually associated with a condition; the difficulties expected in
'participating in activities such as learning and applying knowledge, communication, mobility,
self care, employment, community, social and civic life'; the 'level of support' required and the
'capacity of the family' to provide it; and the 'prospects for new and longer term treatments
and interventions for the condition' (Reproductive Technology Council, 2004). Although the
RTC document refers to the 'embryo', determinations of 'a significant risk of a serious genetic
abnormality or disease' in the embryo are contingent on views about the health of the child
that embryo might become. However, a comprehensive evaluation of the social context in
which the child will live part of any consideration for PGD, and even if such an evaluation is
attempted as directed by the RTC, one cannot determine the level of health, disability and
functioning of the potential child. Although PGD maybe able to detect a marker for a genetic
F
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condition, the manifestation of the condition in the child depends on varying genetic penetrance and the social environment in which the child will live.
The RTC guidelines are also problematic in that apart from an assessment of the
'capacity of the family' to provide support and an inquiry into longer term treatments and
interventions, no other environmental factors, as set out in the ICF, are included. The social
model of disability, upon which the ICF is modelled, requires looking beyond the support
of families to the systemic support of institutions, services, systems, environments and
policies to improve individual functioning, thereby increasing health and well-being and
reducing the incidence of disability. Moreover, although considering the 'prospects for new
and longer term treatments and interventions for the condition' as set out in the RTC
guidelines could be considered to fall within the environmental factor of 'products and
technology', arguably they promote an orientation that further locates the impairment or
disability in the person. Indeed, although the RTC approach attempts to ground determinations of 'seriousness' within a social framework of health and disability, it fails to
include those systemic elements that are essential to an enlightened social model. Rather,
the assessment criteria re-inscribe a conception of disability that is located in the body of
the disabled person. In our view, testing the embryo also operates as a form of 'synecdoche'
(Parens and Asch, 2000; Asch and Wasserman, 2005) in which the part (the genetic
mutation or characteristic) stands in for the whole (the qualities and characteristics of the
person who always exists in a social context).
Because having an impairment is not necessarily incompatible with health or good
quality of life (Amundson, 2005; Asch and Wasserman, 2005; McMahon, 2005), the
regulations in New Zealand and Australia prohibiting the purposeful determination
and implantation of an embryo with a gene for an impairment reflects a particular
conception of health in these (and other) countries. Given that courts have recently
adopted fundamental aspects of the social model of disability (Eldridge v. British Columbia, 1997; Granovsky v. Canada, 2000), a law premised on the idea that particular
genetic traits associated with impairments are inherently incompatible with health or
well-being is difficult to justify. Thus, prohibitions against selecting in favour of
impairments stigmatize the impairment in question and, in many cases, associate
functional limitations inconsistent with the actual lived experience of the condition.
The presumption is that having the genetic mutation is incompatible with health
without the possibility for assessment of actual functional limitation because the
determination is being made in relation to an embryo. Ironically, the same societies
that espouse the goals of including people with disabilities as fully equal and participating members (Eldridge v. British Columbia, 1997; Granovsky v. Canada, 2000) simultaneously promote the use of embryo selection 'to prevent the births of those who would
live with disabilities' (Asch, 2003, p. 315).

Conclusion
Understanding the social determinants of health of embryos offers a counterbalance to the
rapidly expanding technical capacities, clinical applications and research purposes of biomedical determinations of embryo 'health'. Both social and biomedical determinants of
embryo health exist within social contexts and have normative and clinical implications.
Conceptions of the biomedical and social health of children influence conceptions of
embryo health, while biomedical and social determinants of embryo health construct new
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characterizations of the health of children and adults. A distinction must be made between
social, determinants of embryo health that affect the biomedical health of children and
biomedical determinants of embryo health that are perceived to enhance the social health of
children and their parents. The health of embryos, like the health of children and adults,
will always be an unstable concept reflecting the economic, social and political context
within which its meaning is constructed.
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